-
Neurology: poor sleep at night may increase the risk of stroke and heart disease
Time of Update: 2019-11-07
November 8, 2019 / bioun / - recently, a research report published in the international journal Neurology found that people with sleep difficulties (poor sleep) are more likely to suffer from stroke,
-
Scientists have found a link between alcohol consumption and Alzheimer's disease
Time of Update: 2019-11-06
According to the world Alzheimer's 2018 report, every three seconds, there is a dementia patient in the world There are at least 50 million people with dementia around the world In China, there are ab
-
Trans fatty acids may increase the risk of Alzheimer's disease by 50%
Time of Update: 2019-11-05
Recently, an international magazine named "serum elaidic acid concentration and risk of demantia the Hisayama" was published in neurology In the study report, scientists from Kyushu University and oth
-
Recent achievements in Parkinson's disease research
Time of Update: 2019-11-04
November 4, 2019 / BIOON / -- this issue brings you the latest research results in the field of Parkinson's disease I hope readers will like it 1 SCI transl Med: scientists are expected to develop a n
-
Apnm: "high intensity" exercise helps to improve the memory of the elderly
Time of Update: 2019-11-04
November 4, 2019 / bioun / -- dementia is a catastrophic disease affecting about 500000 people in Canada and is expected to rise sharply in the next decade Recently, researchers from McMaster Universi
-
Brain: amazing! Complement system disorder even participate in multiple sclerosis resulting in vision loss!
Time of Update: 2019-11-04
November 4, 2019 / Biovalley / recently, according to a study from Johns Hopkins University School of medicine, scientists have identified three so-called "complement system" genes, which seem to play
-
The latest research progress of Alzheimer's disease
Time of Update: 2019-11-04
November 4, 2019 / BIOON / -- this issue brings you the latest research results related to Alzheimer's disease I hope readers will like it 1 ELife: targeted therapy for metabolic dysfunction or promis
-
Luo Wenbo / yuan Tifei's team found the dynamic change of time perception of methamphetamine addicts during withdrawal
Time of Update: 2019-11-04
Time is one of the most important dimensions of the real world, and human exploration of it has never stopped It is also an eternal topic, philosophers, physicists and so on have been exploring it Tim
-
Nature: it is the first time to reveal the molecular mechanism of intestinal health affecting brain health
Time of Update: 2019-11-04
November 4, 2019 / BIOON / -- recently, in a research report published in the international journal Nature, scientists from will Cornell Medical College and other institutions revealed for the first t
-
Alzheimer's disease research: unfolding the structure of β - amyloid fibrils
Time of Update: 2019-11-04
A neuroscience study carried out by a team of German scientists first reported the structure of β - amyloid fibrils isolated from the brain tissues of patients with Alzheimer's disease and cerebral am
-
It is found that unsupervised transfer learning improves the generalization of machine learning classification based on brain function image data in schizophrenics
Time of Update: 2019-11-03
In the field of clinical research, machine learning has been widely used to optimize brain image data analysis and establish predictive models to classify schizophrenia patients The evaluation of gene
-
Too much salt can lead to mental decline
Time of Update: 2019-11-03
Eating too much salt can lead to cognitive impairment Now scientists may know why It triggers an immune response that leads to the formation of a protein that stops brain cells from working properly T
-
Great news for Alzheimer! China's original therapeutic new drugs, phase 9 and phase 1, have been approved for marketing. There is no new drug market in this field for 17 years
Time of Update: 2019-11-03
November 3, 2019 / BIOON / -- on November 2, 2019, the State Drug Administration approved the listing application of Shanghai Green Valley Pharmaceutical Co., Ltd., a new drug for Alzheimer's disease,
-
Progress in the study of neural circuits regulating sleep structure
Time of Update: 2019-11-03
On October 24, the brain atlas center of the Institute of brain cognition and brain diseases, Shenzhen Institute of advanced technology, Chinese Academy of Sciences, made progress in analyzing the neu
-
SCI Rep: new technology helps judge the health of human hair follicles
Time of Update: 2019-11-02
November 2, 2019 / BIOON / -- many factors can prevent the normal formation and growth of hair, leading to hair diseases and baldness Now, a new method developed by researchers at the Massachusetts Ge
-
Crabs are also complex learners
Time of Update: 2019-11-02
A crab can learn to walk in a maze and still remember it after two weeks The findings suggest that crustaceans, including crabs, lobsters and shrimp, have cognitive abilities for complex learning, alt
-
Curr Biol: the key protein of "braking" in nerve growth
Time of Update: 2019-11-02
November 1, 2019 news / BIOON / -- in the process of embryonic development, nerve cells will form elongated extension structures, which can be used to connect complex brain networks Recently, scientis
-
Mosquito repellent amine provides "invisible cloak" for human body
Time of Update: 2019-11-02
Researchers have been trying to find out how mosquito repellents affect mosquitoes, but the neural response of Anopheles to mosquito repellents and other repellents is largely unknown, because it is a
-
SCI transl Med: scientists are expected to develop new therapies for Parkinson's disease
Time of Update: 2019-11-02
November 3, 2019 / BIOON / -- recently, a report was published in the international journal Science Translational Medicine In the previous report, scientists from Northwestern University in the United
-
New oral drug for multiple sclerosis: vumerity, an upgraded product of Bogen tecfidera, has been approved by the United States. Gastrointestinal tolerance has been greatly improved!
Time of Update: 2019-11-01
November 1, 2019 / BIOON / -- Biogen and partner Alkermes recently announced that the U.S Food and Drug Administration (FDA) has approved vumerity (diroximel Fumarate, biib098), a new oral fumaric aci
